Madeira Therapeutics Developing a Statin, a Cholesterol-Lowering Product, Formulated Specifically for Children  
7/17/2008 12:09:10 PM

LEAWOOD, Kan.--(BUSINESS WIRE)--The American Academy of Pediatrics (AAP) released new guidelines on July 7, 2008, recommending that some children as young as 8 years old be given cholesterol-fighting drugs to ward off future heart problems. It is the strongest guidance ever given by the AAP. Madeira Therapeutics, a pediatric drug-development company, currently has a statin, a cholesterol-lowering product, in the development pipeline focused on this need. The new guidelines set by the AAP are based on evidence showing that damage leading to heart disease, the nation’s leading killer, begins early in life.